Protein-based antigen presentation platforms for nanoparticle vaccines
Abstract Modern vaccine design has sought a minimalization approach, moving to the isolation of antigens from pathogens that invoke a strong neutralizing immune response. This approach has created safer vaccines but may limit vaccine efficacy due to poor immunogenicity. To combat global diseases suc...
Guardado en:
Autores principales: | Brian Nguyen, Niraj H. Tolia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/48d7babf85fb43848b0cf587c51a6749 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
por: Franz X. Heinz, et al.
Publicado: (2021) -
A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform
por: Paul B. Kilgore, et al.
Publicado: (2021) -
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
por: Samir Andrade Mendonça, et al.
Publicado: (2021) -
Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
por: Sonia Budroni, et al.
Publicado: (2021) -
A cell-based in vitro assay for testing of immunological integrity of Tetanus toxoid vaccine antigen
por: Olga Ticha, et al.
Publicado: (2021)